港股异动 | 创新药概念股集体走低加息预期压制行业估值及投融资环境市场关注ASCO会议进展

智通财经05-28

智通财经APP获悉，创新药概念股集体走低，截至发稿，翰森制药(03692)跌6.69%，报31.54港元；和黄医药(00013)跌4.81%，报17.8港元；信达生物(01801)跌4.05%，报75.75港元；中生制药(01177)跌3.4%，报4.83港元。消息面上，中东冲突引发的能源通胀正从预期演变为现实压力，全球主要发达经济体央行密集释放加息信号。国海证券在风险提示中指出，若全球及国内宏观...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2638166837?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-28 15:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2638166837","market":"us","top_or_hot":-1,"title":"港股异动 | 创新药概念股集体走低 加息预期压制行业估值及投融资环境 市场关注ASCO会议进展","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，创新药概念股集体走低，截至发稿，翰森制药(03692)跌6.69%，报31.54港元；和黄医药(00013)跌4.81%，报17.8港元；信达生物(01801)跌4.05%，报75.75港元；中生制药(01177)跌3.4%，报4.83港元。消息面上，中东冲突引发的能源通胀正从预期演变为现实压力，全球主要发达经济体央行密集释放加息信号。国海证券在风险提示中指出，若全球及国内宏观...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1447074.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 创新药概念股集体走低 加息预期压制行业估值及投融资环境 市场关注ASCO会议进展</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 创新药概念股集体走低 加息预期压制行业估值及投融资环境 市场关注ASCO会议进展\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-28 15:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1447074.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，创新药概念股集体走低，截至发稿，翰森制药(03692)跌6.69%，报31.54港元；和黄医药(00013)跌4.81%，报17.8港元；信达生物(01801)跌4.05%，报75.75港元；中生制药(01177)跌3.4%，报4.83港元。消息面上，中东冲突引发的能源通胀正从预期演变为现实压力，全球主要发达经济体央行密集释放加息信号。国海证券在风险提示中指出，若全球及国内宏观...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1447074.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VXUS","symbol_name":"国际股票ETF-Vanguard","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1447074.html","article_id":"2638166837","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2638166837","pubTimestamp":1779952150,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"创新药、CXO 等成长赛道对流动性较为敏感，若美联储降息周期延后，或国内降准降息落地不及预期，市场流动性收紧将直接压制成长赛道估值。值得注意的是，2026年美国临床肿瘤学会年会将于5月29日至6月2日在美国芝加哥举行。本届ASCO共63项研究入选LBA，其中12家企业的13项研究来自中国，创历史新高；同时，94项中国研究入选口头汇报，数量近三年快速增长。上海证券指出，中国药企在国际平台彰显实力，中国创新药全球话语权逐年提升。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","VXUS":"国际股票ETF-Vanguard","BK1589":"北水核心资产","BK4588":"碎股","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","BK1588":"回港中概股","06978":"永泰生物-B","BK1191":"制药","BK1161":"生物科技","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU0502904849.HKD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (HKD) ACC","BK1515":"抗疫概念","IE00BZ08YR35.GBP":"GUINNESS BEST OF CHINA \"C\" (GBP) ACC","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","BK4585":"ETF&股票定投概念","BK1587":"次新股","BK1574":"生物医药B类股","IE00BZ08YS42.EUR":"GUINNESS BEST OF CHINA \"C\" (EUR) ACC","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","01177":"中国生物制药","BK1583":"高瓴概念","IE00BZ08YT58.USD":"GUINNESS BEST OF CHINA \"C\" (USD) ACC","BK1521":"挪威政府全球养老基金持仓","03692":"翰森制药","01801":"信达生物","LU0455707207.USD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","00013":"和黄医药","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD"},"translate_title":"Changes in Hong Kong stocks | Innovative drug concept stocks collectively fell rate hike expectations suppressed industry valuation and investment and financing environment The market paid attention to the progress of the ASCO meeting","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1.5,"01177":0.9,"VXUS":1.5,"01801":0.9,"00013":0.9,"03692":0.9,"06978":1.5},"content_text":"智通财经APP获悉，创新药概念股集体走低，截至发稿，翰森制药(03692)跌6.69%，报31.54港元；和黄医药(00013)跌4.81%，报17.8港元；信达生物(01801)跌4.05%，报75.75港元；中生制药(01177)跌3.4%，报4.83港元。消息面上，中东冲突引发的能源通胀正从预期演变为现实压力，全球主要发达经济体央行密集释放加息信号。国海证券在风险提示中指出，若全球及国内宏观货币政策节奏不及预期，将直接影响医药板块的估值水平与投融资环境。创新药、CXO 等成长赛道对流动性较为敏感，若美联储降息周期延后，或国内降准降息落地不及预期，市场流动性收紧将直接压制成长赛道估值。值得注意的是，2026年美国临床肿瘤学会（ASCO）年会将于5月29日至6月2日在美国芝加哥举行。本届ASCO共63项研究入选LBA（最新突破性摘要），其中12家企业的13项研究来自中国，创历史新高；同时，94项中国研究入选口头汇报，数量近三年快速增长。上海证券指出，中国药企在国际平台彰显实力，中国创新药全球话语权逐年提升。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2638166837","isCrawlerRequest":true}

港股异动 | 创新药概念股集体走低 加息预期压制行业估值及投融资环境 市场关注ASCO会议进展

精彩评论

港股异动 | 创新药概念股集体走低加息预期压制行业估值及投融资环境市场关注ASCO会议进展